This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
: GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo - JSON Representation
Raw json | Download
{
"resourceType" : "EvidenceVariable",
"id" : "179689",
"meta" : {
"versionId" : "4",
"lastUpdated" : "2023-12-04T15:43:55.736Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: EvidenceVariable</b><a name=\"179689\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource EvidenceVariable "179689" Version "4" Updated "2023-12-04 15:43:55+0000" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-group-assignment.html\">GroupAssignment</a></p></div><p><b>EvidenceVariableDefinition</b>: Defined in handling and category elements <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-handling-and-category)</span></p><p><b>StructureDefinition Work Group</b>: cds</p><p><b>url</b>: <code>https://fevir.net/resources/EvidenceVariable/179689</code></p><p><b>identifier</b>: FEvIR Object Identifier:\u00a0179689</p><p><b>version</b>: 1.0.0-ballot</p><p><b>name</b>: GroupAssignment_high_dose_xanomeline_vs_low_dose_xanomeline_vs_placebo</p><p><b>title</b>: GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo</p><p><b>status</b>: active</p><p><b>date</b>: 2023-12-17 16:55:23+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href=\"http://www.hl7.org/Special/committees/dss\">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: This example of a GroupAssignment Profile describes a 3-arm trial (so handling='polychotomous') and lists the 3 trial arms in category.name elements. Because the definition of this EvidenceVariable Resource is fully expressed in the handling and category elements, the defintion.concept element uses a CodeableConcept for 'Defined in handling and category elements'.</p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication')</td><td>GroupAssignment <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#GroupAssignment)</span></td></tr></table><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>author</b>: Brian S. Alper: </p><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style=\"display: none\">*</td><td>cite-as</td><td>GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179689. Revised 2023-12-01. Available at: https://fevir.net/resources/EvidenceVariable/179689. Computable resource at: https://fevir.net/resources/EvidenceVariable/179689.</td></tr></table><p><b>handling</b>: polychotomous</p><blockquote><p><b>category</b></p><p><b>name</b>: high dose xanomeline</p></blockquote><blockquote><p><b>category</b></p><p><b>name</b>: low dose xanomeline</p></blockquote><blockquote><p><b>category</b></p><p><b>name</b>: placebo</p></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-definition",
"valueCodeableReference" : {
"concept" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "defined-in-handling-and-category",
"display" : "Defined in handling and category elements"
}
]
}
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "cds"
}
],
"url" : "https://fevir.net/resources/EvidenceVariable/179689",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "179689",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"version" : "1.0.0-ballot",
"name" : "GroupAssignment_high_dose_xanomeline_vs_low_dose_xanomeline_vs_placebo",
"title" : "GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo",
"status" : "active",
"date" : "2023-12-17T16:55:23+00:00",
"publisher" : "HL7 International / Clinical Decision Support",
"contact" : [
{
"name" : "HL7 International / Clinical Decision Support",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/dss"
}
]
}
],
"description" : "This example of a GroupAssignment Profile describes a 3-arm trial (so handling='polychotomous') and lists the 3 trial arms in category.name elements. Because the definition of this EvidenceVariable Resource is fully expressed in the handling and category elements, the defintion.concept element uses a CodeableConcept for 'Defined in handling and category elements'.",
"useContext" : [
{
"code" : {
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "evidence-communication",
"display" : "Evidence Communication"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "GroupAssignment",
"display" : "GroupAssignment"
}
]
}
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"author" : [
{
"name" : "Brian S. Alper"
}
],
"relatedArtifact" : [
{
"type" : "cite-as",
"citation" : "GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179689. Revised 2023-12-01. Available at: https://fevir.net/resources/EvidenceVariable/179689. Computable resource at: https://fevir.net/resources/EvidenceVariable/179689."
}
],
"handling" : "polychotomous",
"category" : [
{
"name" : "high dose xanomeline"
},
{
"name" : "low dose xanomeline"
},
{
"name" : "placebo"
}
]
}
|
Propose a change